Labs, Pathologists Aim to Delay 2023 Medicare Fee Schedule Cuts
As clinical laboratories and pathology groups prepare to operate outside of the Covid Public Health Emergency for the first time in years, many are turning an eye toward Medicare fee schedule cuts that could be reinstated after years of delays. According to Ann... How SALSA Would Create a Sustainable Clinical Lab Fee Schedule
Although clinical laboratories have experienced drastic Medicare rate reductions since the introduction of the Protecting Access to Medicare Act (PAMA) required them to begin reporting private payer data to Medicare in 2017, several pandemic-related delays in recent...
MIPS 2023: Reporting for Pathologists
By: Beth Madden, Client Administrator CMS has announced what lies ahead for the Merit-based Incentive Payment System (MIPS) program with proposed adjustments for the 2023 performance year, which impacts Medicare Part B payments in 2025. RELATED: 2023 Medicare... Improving Denial Management Through Artificial Intelligence
As CMS and private payors have increased the use of Medically Unlikely Edits and prior authorization programs over that past decade to control costs and utilization, providers and their billers have had to commit an increasing amount of time and resources to denial... 
Lighthouse Acquires MJB Lab Consulting, Expanding Medical Leadership Services